MTAU9937A Uses, Dosage, Side Effects and more
MTAU9937A is under investigation in clinical trial NCT03289143 (A Study to Evaluate the Efficacy and Safety of RO7105705 in Patients With Prodromal to Mild Alzheimer's Disease).
| Trade Name | MTAU9937A |
| Generic | Semorinemab |
| Semorinemab Other Names | MTAU9937A, Semorinemab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
